Success Story: Advancing Cardiovascular Medicine Research: NIW Approval After RFE Secured for a Medical Researcher from Pakistan
Client’s Testimonial:
"I wanted to sincerely thank you for all the help. It was really a great experience working with you guys.”
On June 22nd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Resident Physician in the field of Cardiovascular Medicine (Approval Notice).
General Field: Cardiovascular Medicine
Position at the Time of Case Filing: Resident Physician
Country of Origin: Pakistan
State of Residence at the Time of Case Filing: New York
Approval Notice Date: June 22nd, 2026
Processing Time: 6 months, 12 days (Premium Processing Upgrade Requested)
Case Summary:
The client’s work focuses on an urgent challenge in cardiovascular medicine, namely, how to improve clinical outcomes, reduce healthcare costs, and mitigate disparities in cardiovascular disease care. His proposed endeavor centered on conducting observational studies, clinical trials, meta-analyses, and cost-effectiveness analyses to study cardiovascular disease epidemiology, pathogenesis, and management, with a focus on atrial fibrillation and ischemic heart disease. At the time of filing, the client was employed as a resident physician at a U.S. academic medical institution while continuing cardiovascular medicine research.
Research with National Importance
The client’s research addresses a major public health concern because cardiovascular disease remains one of the leading causes of death and long-term healthcare burden. His work is designed to generate evidence that can improve clinical decision-making, support more equitable care, and help reduce the economic impact of cardiovascular disease in the United States. We demonstrated that his research is nationally important because it aligns with the need to improve cardiovascular outcomes, reduce disparities among affected populations, and strengthen evidence-based treatment strategies.
Academic Contributions and Recognition
At the time of filing, the client’s record included an MBBS in medicine, 24 peer-reviewed journal articles, including 15 first- or co-first-authored articles, 19 abstracts, including 3 first-authored abstracts, 56 citations, and at least 9 completed peer reviews.
Rather than presenting these figures as automatically persuasive, we explained how they would likely be interpreted in context. The publications showed a substantial and focused research record in cardiovascular medicine, the citations reflected independent reliance on the client’s findings by other researchers, and the peer-review invitations demonstrated that journals trusted his expertise in cardiovascular disease, epidemiology, and clinical outcomes research.
We also highlighted that several of the client’s papers were cited at notable rates in Clinical Medicine, including 4 papers ranked among the top 10% and 1 paper ranked among the top 20% most-cited articles for their respective publication years. This helped show that the client’s work had attracted recognition beyond ordinary publication activity.
Demonstrating the Client’s Significance
We demonstrated the client’s significance by showing how independent researchers had relied on his work involving pulsed field ablation for atrial fibrillation, endothelial function, cardiovascular outcomes in cancer patients with type 2 diabetes, and cardiovascular mortality trends. These examples showed that the client’s research had practical value in advancing clinical understanding of cardiovascular interventions and patient outcomes.
The petition also emphasized the client’s ability to conduct systematic reviews, meta-analyses, and observational studies that synthesize complex clinical evidence and identify trends relevant to patient care, health disparities, and cost-effective treatment. This helped connect the client’s scholarly work to broader public health needs rather than presenting it as an isolated academic output.
NIW Approval and Outlook
After USCIS issued a Request for Evidence (RFE), we further clarified the national importance of the proposed endeavor and the client’s strong positioning to advance it. The response connected the client’s research record, independent scholarly reliance, peer-review activity, and future plans to the Dhanasar framework, showing that his continued work would benefit the United States.
The I-140 NIW petition was filed on December 10th, 2025, later upgraded to Premium Processing, and approved on June 22nd, 2026. We congratulate the client on this I-140 NIW approval after RFE and look forward to his continued contributions to cardiovascular medicine, evidence-based care, and public health research in the United States.